<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04199273</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL19_0202</org_study_id>
    <nct_id>NCT04199273</nct_id>
  </id_info>
  <brief_title>Assessment of Human Diaphragm Strength by Magnetic and Electric Stimulation After Ultrasonography Phrenic Nerve Tracking</brief_title>
  <acronym>SONOSTIM</acronym>
  <official_title>Assessment of Human Diaphragm Strength by Magnetic and Electric Stimulation After Ultrasonography Phrenic Nerve Tracking : a Randomized, Cross Over, Physiologic Study in Critically Ill Patients Requiring Invasive Mechanical Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Development and validation of a new affordable and easy-to-use phrenic nerve stimulation tool
      for diaphragm strength assessment in intensive care unit
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In intensive care unit, various forms of sepsis, undernutrition, surgery, global
      inflammation, iatrogeny, and mechanical ventilation, contribute to the overall muscular
      involvement including the diaphragm.

      Assessment of diaphragm dysfunction is a critical issue for patients under mechanical
      ventilation, providing prognosis information and leading to the best therapeutic choices.

      Up to now, for sedated ventilated critical care patient, expensive magnetic phrenic nerve
      stimulation equipment is needed to evaluate diaphragm strength.

      In this study, the investigators aim to develop an affordable easy-to-use phrenic nerve
      stimulation tool, with ultrasonography and a nerve stimulator usually used for neuromuscular
      transmission monitoring. Hypothesis is that phrenic pacing using this new method is
      equivalent to the Gold Standard.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 30, 2019</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Each patient, serving as their own control, receives both types of phrenic nerve stimulation : magnetic stimulation and electric stimulation. The order is randomized. For avoid a carry-over effect (diaphragm potentiation), a wash-out period of 15 minutes will be respected between the two type of stimulation.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tracheal pressure (Ptrach) during diaphragm pacing</measure>
    <time_frame>During electric of magnetic phrenic nerve stimulation</time_frame>
    <description>Negative pressure in the occluded breathing circuit, assessed with a manometer located just after the endotracheal tube, during diaphragm stimulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Behavioral Pain Scale (BPS) after stimulation</measure>
    <time_frame>Immediately after phrenic nerve stimulation</time_frame>
    <description>The BPS is a scale of pain for critical care patients, from 3 (no or minimal pain) to 12 points (maximum pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distance in millimeter between anatomical and ultrasound phrenic nerve location</measure>
    <time_frame>During ultrasonography phrenic nerve tracking</time_frame>
    <description>Distance between classical anatomical landmarks of the phrenic nerve location (underneath the posterior border of the sternocleidomastoid muscle, at the level of the cricoid cartilage), and the phrenic nerve location with ultrasound</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Intensive Care Unit</condition>
  <condition>Invasive Mechanical Ventilation</condition>
  <arm_group>
    <arm_group_label>Magnetic stimulation and electric stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient receive first the magnetic stimulation with MagStim 200 tool. Then 15 min after he will receive the electric stimulation with the SonoStim tool : ultrasonography phrenic nerve tracking and targeted electric stimulation with a nerve stimulator usually used for neuromuscular transmission monitoring (TOFScan, Drager)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electric stimulation and magnetic stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient receive first electric stimulation with the SonoStim tool : ultrasonography phrenic nerve tracking and targeted electric stimulation with a nerve stimulator usually used for neuromuscular transmission monitoring (TOFScan, Drager). Then 15 min after he will receive the magnetic stimulation with MagStim 200 tool</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Magnetic stimulation</intervention_name>
    <description>Cervical bilateral phrenic nerve stimulation with the MagStim 200 tool.</description>
    <arm_group_label>Electric stimulation and magnetic stimulation</arm_group_label>
    <arm_group_label>Magnetic stimulation and electric stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electric stimulation</intervention_name>
    <description>Cervical bilateral phrenic nerve stimulation after ultrasonography nerve tracking and targeted electric stimulation with a nerve stimulator usually used for neuromuscular transmission monitoring (TOFScan, Drager)</description>
    <arm_group_label>Electric stimulation and magnetic stimulation</arm_group_label>
    <arm_group_label>Magnetic stimulation and electric stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICU patient with invasive mechanical ventilation

          -  Sedated patient with a Richmond Agitation-Sedation Scale of -4 or -5

        Exclusion Criteria:

          -  Contraindication for magnetic stimulation (Pacemaker)

          -  Hemodynamic or respiratory instability : PaO2/FiO2 &lt; 300 mmHg, noradrenaline &gt; 0,3
             µg/kg/min, dobutamine &gt; 10 µg/kg/min

          -  Neuromuscular disease or recent use of neuromuscular blocking agents (2h30) with a TOF
             ratio below 4/4 95%.

          -  Refusal of study participation or to pursue the study by the patient, no consent

          -  Pregnancy or breastfeeding

          -  Absence of coverage by the French statutory healthcare insurance system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samir Jaber, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Montpellier University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Audrey De Jong, MD, PHD</last_name>
    <phone>0033467337271</phone>
    <email>a-de_jong@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samir Jaber, MD, PHD</last_name>
    <phone>0033467337271</phone>
    <email>s-jaber@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Saint Eloi</name>
      <address>
        <city>Montpellier</city>
        <state>Herault</state>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir H Jaber, MD, PHD</last_name>
      <phone>0033467337271</phone>
      <phone_ext>0033467337271</phone_ext>
      <email>s-jaber@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Audrey H De Jong, MD, PHD</last_name>
      <phone>0033467337271</phone>
      <phone_ext>0033467337271</phone_ext>
      <email>a-de_jong@chu-montpellier.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Samir Jaber, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey De Jong, MD, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gerald Chanques, MD, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathieu Capdevila</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2019</study_first_posted>
  <last_update_submitted>January 6, 2020</last_update_submitted>
  <last_update_submitted_qc>January 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intensive Care Unit</keyword>
  <keyword>Invasive Mechanical Ventilation</keyword>
  <keyword>Diaphragm weakness assessment</keyword>
  <keyword>Rehabilitation</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual patient data will be made available upon a reasonable request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>12 months after the main publication</ipd_time_frame>
    <ipd_access_criteria>Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and institutional review board (IRB) review. Dataset will be shared after careful examination by the study board of investigators.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

